These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 311566)

  • 21. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Treatment of systemic lupus erythematosus with levamisole.
    Kassan SS
    Ann Allergy; 1976 Aug; 37(2):148-50. PubMed ID: 970682
    [No Abstract]   [Full Text] [Related]  

  • 23. [The importance of immunofluorescence examinations in the diagnosis of lupus erythematosus (author's transl)].
    Gligora M
    Lijec Vjesn; 1977 Apr; 99(4):250-4. PubMed ID: 329027
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic lupus erythematosus with generalized chronic cutaneous (discoid) lupus erythematosus.
    Dadlani C; Pulitzer M; Prystowsky SD
    Dermatol Online J; 2008 May; 14(5):5. PubMed ID: 18627741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Presocyl in the treatment of lupus erythematosus].
    Glavinskaia TA; Zernov VP; Ostroumova TN
    Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperkeratotic nail discoid lupus erythematosus evolving towards systemic lupus erythematosus: therapeutic difficulties.
    Richert B; André J; Bourguignon R; de la Brassinne M
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):728-30. PubMed ID: 15482310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucocutaneous lupus erythematosus.
    Piamphongsant T; Chaikittisilpa S
    J Med Assoc Thai; 1979 Dec; 62(12):661-6. PubMed ID: 536655
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical cases and laboratory data in a group of mesenchymopathies: lupus erythematosus, dermatomyositis, scleroderma].
    Meneghini CL; Bonifazi E
    J Med Lyon; 1972 Sep; 53(232):1123-31. PubMed ID: 4539165
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thermography in examining lupus erythematosus patients].
    Sablina ME; Kuznetsova IK
    Vestn Dermatol Venerol; 1979 Jan; (1):64-6. PubMed ID: 419882
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complement fixation test with collagen antigen in patients with different forms of lupus erythematosus].
    Lomkin AN; Zisel'son AD; Zubzhitskiĭ IuN
    Vestn Dermatol Venerol; 1967 Nov; 41(11):38-42. PubMed ID: 5621354
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical aspects of chronic lupus erythematosus in a markedly continental climate].
    Grebennikov VA; Gavrilenko VE
    Vestn Dermatol Venerol; 1984 May; (5):20-4. PubMed ID: 6234716
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunosuppression of burn patients. Treatment with levamisole].
    Renoux G; Renoux M; Greco JM
    Ann Chir Plast; 1979; 24(1):57-9. PubMed ID: 317422
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blepharitis--rare in systemic lupus erythematosus].
    Gyl F; Anna-Adrien C; Oanţă A; Irimie M; Edit FJ
    Oftalmologia; 2008; 52(2):81-3. PubMed ID: 19065920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
    Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
    Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis, diagnosis and therapy of transitional (presystemic) forms of lupus erythematosus].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1981 Nov; (11):4-7. PubMed ID: 6976049
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lysozyme in the combined therapy of erythematosis].
    Glavinskaia TA; Pavlova LT; Dorofeĭchuk VG
    Vestn Dermatol Venerol; 1990; (3):21-5. PubMed ID: 2368487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunofluorescent "band" test for lupus erythematosus. I. Morphologic variations of the band of localized immunoglobulins at the dermal-epidermal junction in lupus erythematosus.
    Burnham TK; Fine G
    Arch Dermatol; 1969 Apr; 99(4):413-20. PubMed ID: 4181409
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical picture and course of chronic lupus erythematosus between 1959 and 1969].
    Mieczyńska-Wójcik Z
    Przegl Dermatol; 1971; 58(5):587-93. PubMed ID: 5139058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.